Sabra Healthcare Reit

Forecast & Rating16 analysts currently cover Sabra Healthcare Reit, with about 37.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $22.71, about 1.6% upside from the current price of $22.36. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 50.7% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Sabra Healthcare Reit's outlook. Data as of Jul 22, 2026; for reference only and not investment advice.